Beijing Bio-targeting Therapeutics Technology Co., Ltd

This study tests a new treatment for people with recurrent high-grade glioma, a serious brain cancer that has come back after standard therapy. The treatment uses a modified virus (oncolytic adenovirus) designed to infect and kill cancer cells while also boosting the immune syste…

This early-phase study tests a new treatment called BioTTT001, a modified virus designed to infect and kill cancer cells while boosting the immune system. It involves 12 adults with advanced solid tumors (like head and neck, colorectal, skin, or cervical cancer) who have not resp…

This study was designed to test the safety and effectiveness of a new virus-based treatment (BioTTT001) combined with standard pre-surgery therapy for women with locally advanced breast cancer. The trial was withdrawn before enrolling any participants, so no results are available…